fbpx

Folks, let me tell you about a stock that’s been making waves in the healthcare sector. Portage Biotech Inc., or PRTG for short, has seen its value skyrocket by an astonishing 133.59% over the past week alone. Now, I know what you’re thinking – “Jeff, how can one company go from $3 to nearly $10 in such a short amount of time?” Well, let me tell you, it’s not just about the numbers; it’s about the potential.

PRTG is working on some cutting-edge research and development of immuno-oncology therapies for cancer patients. Their portfolio includes innovative treatments that could make all the difference in the fight against this devastating disease. But here’s the thing – we’re talking about a company with a market cap under $12 million, so it’s not exactly a household name.

Now, I’m not going to sugarcoat it; PRTG is a high-risk stock. The volatility is off the charts, and you can expect some wild swings in its value over time. But that doesn’t mean we should be afraid of it. In fact, sometimes these kinds of stocks are exactly what investors need – a chance to get in on something big before everyone else.

But let’s talk about the risks first. PRTG has had some significant losses in recent years, and its financials aren’t exactly rosy. The company is burning through cash at an alarming rate, with net income of -$67 million last year alone. And don’t even get me started on the debt/equity ratio – a whopping $0.02 per share.

So what’s driving this stock up? Well, for one thing, PRTG has been making some big moves in its research and development department. They’ve announced partnerships with other companies to further their cancer treatments, which could lead to significant growth down the line. And let me tell you, these deals can be game-changers.

But here’s the thing – we’re not going to give you a buy or sell recommendation on this stock. We’re just giving it to you straight, no chaser. If you’re interested in staying up-to-date with PRTG and other high-risk stocks like it, sign up for our free daily SMS alerts by texting “RBWebsite” to (888) 404-5747.

We’ll keep an eye on this stock and bring you the latest news and updates as they happen. And who knows – if we’re right, you might just be in position to make some big gains. But remember, with great power comes great risk. Always do your own research and never invest more than you can afford to lose.

So there you have it, folks – PRTG: a high-risk, high-reward opportunity that’s got everyone talking. Stay tuned for more updates on this wild ride.

Author:
Jeff Bishop

One of the best traders anywhere, over the past 20 years Jeff’s made multi-millions trading stocks, ETFs, and options. He is renowned as an incredible trader with a deep insight and a sensitive pulse on the markets and the economy. Jeff Bishop is CEO and Co-Founder of RagingBull.com.

Even greater than his prowess as a trader is his skill and passion in teaching others how to trade and rake in profits while managing risk.

Learn More

Leave your comment

Skip to content